- Home
- LNTH vs G Comparison
LNTH vs G Comparison
Compare LNTH & G Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LNTH
- G
- Stock Information
- Founded
- LNTH 1956
- G 1997
- Country
- LNTH United States
- G Bermuda
- Employees
- LNTH N/A
- G N/A
- Industry
- LNTH Biotechnology: In Vitro & In Vivo Diagnostic Substances
- G Professional Services
- Sector
- LNTH Health Care
- G Consumer Discretionary
- Exchange
- LNTH Nasdaq
- G Nasdaq
- Market Cap
- LNTH 7.5B
- G 7.4B
- IPO Year
- LNTH 2015
- G 2007
- Fundamental
- Price
- LNTH $79.19
- G $40.64
- Analyst Decision
- LNTH Strong Buy
- G Buy
- Analyst Count
- LNTH 5
- G 7
- Target Price
- LNTH $133.80
- G $48.57
- AVG Volume (30 Days)
- LNTH 1.0M
- G 1.4M
- Earning Date
- LNTH 07-30-2025
- G 08-07-2025
- Dividend Yield
- LNTH N/A
- G 1.67%
- EPS Growth
- LNTH N/A
- G N/A
- EPS
- LNTH 3.53
- G 2.94
- Revenue
- LNTH $1,536,699,000.00
- G $4,850,828,000.00
- Revenue This Year
- LNTH $4.63
- G $5.77
- Revenue Next Year
- LNTH $9.35
- G $5.79
- P/E Ratio
- LNTH $22.44
- G $13.82
- Revenue Growth
- LNTH 12.53
- G 7.35
- 52 Week Low
- LNTH $73.11
- G $30.38
- 52 Week High
- LNTH $126.89
- G $56.76
- Technical
- Relative Strength Index (RSI)
- LNTH 44.57
- G 32.25
- Support Level
- LNTH $76.34
- G $42.77
- Resistance Level
- LNTH $84.36
- G $44.12
- Average True Range (ATR)
- LNTH 2.69
- G 0.88
- MACD
- LNTH 0.66
- G -0.02
- Stochastic Oscillator
- LNTH 48.07
- G 4.66
About LNTH Lantheus Holdings Inc.
Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its products are in three categories: Precision Diagnostics, Radiopharmaceutical Oncology, and Strategic Partnerships and Other Revenue. Precision Diagnostic products assist healthcare professionals Find and Follow diseases, with a focus in cardiology. Radiopharmaceutical Oncology diagnostics and therapeutics help HCPs Find, Fight and Follow cancer. Strategic Partnerships focus on enabling precision medicine through the use of biomarkers, digital solutions and pharma services platforms, and also includes license of RELISTOR to Bausch Health Companies, Inc.
About G Genpact Limited
Genpact Ltd is a provider of business process management services. Clients are industry verticals and operate in banking and financial services, insurance, capital markets, consumer product goods, life sciences, infrastructure, manufacturing and services, healthcare, and high-tech. Genpact's services include aftermarket, direct procurement, risk and compliance, human resources, IT, industrial solutions, collections, finance and accounting, and media services. Genpact's end market by revenue is India. It is a General Electric spin-off, which is still a large source of revenue for Genpact.